LNTH — Lantheus Holdings Share News
0.000.00%
Last trade - 00:00- $7.15bn
- $7.22bn
- $1.54bn
Lantheus, Point Bio slide as cancer drug data misses expectations
Lantheus Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Lantheus Holdings Q3 Adjusted EPS USD 1.47 Vs. IBES Estimate USD 1.32
Lantheus Holdings Inc expected to post earnings of $1.32 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Anixa, Nano-X Imaging, Structure Therapeutics
U.S. STOCKS ON THE MOVE-Oddity Tech, Netflix, Warby Parker
Lantheus jumps as partner Point Biopharma agrees to Eli Lilly deal
Lantheus Holdings jumps as Lilly to buy co's partner Point Biopharma
U.S. STOCKS ON THE MOVE-Mercato, Baytex, Ball Corp
U.S. STOCKS ON THE MOVE-SeaStar, Sigma Lithium, Brinker
William Blair upbeat on Lantheus Holdings' radiopharmaceutical opportunity
Brief: Lantheus Holdings Inc Says Board Elevated Level Of Robert J. Marshall, Jr.’s Role As CFO, Treasurer Of Co, Its Subsidiaries, Effective August 28
Brief: Lantheus Says On Aug 15 A Unit Decided To Discontinue Production & Promotion Of Azedra
Brief: Lantheus Announces Agreement To Sell RELISTOR Royalties To Healthcare Royalty
Lantheus Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Lantheus Holdings Q2 Adjusted EPS USD 1.54 Vs. IBES Estimate USD 1.31
Lantheus Holdings Inc expected to post earnings of $1.31 a share - Earnings Preview
Lantheus Holdings Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Peloton, New Fortress Energy, Qualcomm